Literature DB >> 10403250

Mox2 is a component of the genetic hierarchy controlling limb muscle development.

B S Mankoo1, N S Collins, P Ashby, E Grigorieva, L H Pevny, A Candia, C V Wright, P W Rigby, V Pachnis.   

Abstract

The skeletal muscles of the limbs develop from myogenic progenitors that originate in the paraxial mesoderm and migrate into the limb-bud mesenchyme. Among the genes known to be important for muscle development in mammalian embryos are those encoding the basic helix-loop-helix (bHLH) myogenic regulatory factors (MRFs; MyoD, Myf5, myogenin and MRF4) and Pax3, a paired-type homeobox gene that is critical for the development of limb musculature. Mox1 and Mox2 are closely related homeobox genes that are expressed in overlapping patterns in the paraxial mesoderm and its derivatives. Here we show that mice homozygous for a null mutation of Mox2 have a developmental defect of the limb musculature, characterized by an overall reduction in muscle mass and elimination of specific muscles. Mox2 is not needed for the migration of myogenic precursors into the limb bud, but it is essential for normal appendicular muscle formation and for the normal regulation of myogenic genes, as demonstrated by the downregulation of Pax3 and Myf5 but not MyoD in Mox2-deficient limb buds. Our findings show that the MOX2 homeoprotein is an important regulator of vertebrate limb myogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403250     DOI: 10.1038/21892

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  45 in total

1.  EMBO Workshop Report: Molecular genetics of muscle development and neuromuscular diseases Kloster Irsee, Germany, September 26-October 1, 1999.

Authors:  T Brand; G Butler-Browne; E M Füchtbauer; R Renkawitz-Pohl; B Brand-Saberi
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

Review 2.  The formation of skeletal muscle: from somite to limb.

Authors:  Margaret Buckingham; Lola Bajard; Ted Chang; Philippe Daubas; Juliette Hadchouel; Sigolène Meilhac; Didier Montarras; Didier Rocancourt; Frédéric Relaix
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

3.  Meox homeodomain proteins are required for Bapx1 expression in the sclerotome and activate its transcription by direct binding to its promoter.

Authors:  Isabel Rodrigo; Paola Bovolenta; Baljinder S Mankoo; Kenji Imai
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 4.  Myogenesis and muscle regeneration.

Authors:  Faisal Yusuf; Beate Brand-Saberi
Journal:  Histochem Cell Biol       Date:  2012-05-27       Impact factor: 4.304

5.  A novel genetic hierarchy functions during hypaxial myogenesis: Pax3 directly activates Myf5 in muscle progenitor cells in the limb.

Authors:  Lola Bajard; Frédéric Relaix; Mounia Lagha; Didier Rocancourt; Philippe Daubas; Margaret E Buckingham
Journal:  Genes Dev       Date:  2006-09-01       Impact factor: 11.361

6.  Six proteins regulate the activation of Myf5 expression in embryonic mouse limbs.

Authors:  Julien Giordani; Lola Bajard; Josiane Demignon; Philippe Daubas; Margaret Buckingham; Pascal Maire
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

Review 7.  Myotome meanderings. Cellular morphogenesis and the making of muscle.

Authors:  Georgina E Hollway; Peter D Currie
Journal:  EMBO Rep       Date:  2003-09       Impact factor: 8.807

8.  Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens.

Authors:  Richard R Almon; Debra C DuBois; Zhenling Yao; Eric P Hoffman; Svetlana Ghimbovschi; William J Jusko
Journal:  Physiol Genomics       Date:  2007-05-01       Impact factor: 3.107

9.  Combined p53- and PTEN-deficiency activates expression of mesenchyme homeobox 1 (MEOX1) required for growth of triple-negative breast cancer.

Authors:  Mari Gasparyan; Miao-Chia Lo; Hui Jiang; Chang-Ching Lin; Duxin Sun
Journal:  J Biol Chem       Date:  2020-05-28       Impact factor: 5.157

Review 10.  Other model organisms for sarcomeric muscle diseases.

Authors:  John Sparrow; Simon M Hughes; Laurent Segalat
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.